about
High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals.A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosisModular programming for tuberculosis control, the "AuTuMN" platform.Optimally capturing latency dynamics in models of tuberculosis transmission.Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis studyAppropriate comparisons of tuberculosis latency structures with empiric dataProfiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries
P50
Q28365057-0747E455-01CA-46FD-82A2-30B3BE8EA77EQ33629597-02F41980-66C5-45D5-90E7-31FEDEB7F70AQ33743661-1485F3C5-B43B-4080-8BCC-CF68BFFBF16BQ38645894-9D318F1B-0678-4A40-A35B-FD4976449A0EQ38667848-B4CD5794-C07E-446D-8203-15E83CD298C9Q57184932-4490953E-D72F-4DDD-938B-BB88A879EC44Q89433275-946AD20B-684E-4FA4-BBF0-528008D4113CQ91380909-8F5ADF92-3679-4C2B-B611-4E144CE36C4A
P50
description
researcher
@en
wetenschapper
@nl
name
Romain Ragonnet
@en
Romain Ragonnet
@nl
type
label
Romain Ragonnet
@en
Romain Ragonnet
@nl
prefLabel
Romain Ragonnet
@en
Romain Ragonnet
@nl
P31
P496
0000-0001-8520-2362